View Information Collection Request (ICR) Package

OMB Control No: 0920-1011	ICR Reference No: 202610-0920-022
Status: Active	Previous ICR Reference No: 202509-0920-005
Agency/Subagency: HHS/CDC	Agency Tracking No: 0920-1011
Title: [OS] Emergency Epidemic Investigation Data Collections
Type of Information Collection: No material or nonsubstantive change to a currently approved collection	Common Form ICR: No
Type of Review Request: Regular
OIRA Conclusion Action: Approved without change	Conclusion Date: 10/27/2026
	Date Received in OIRA: 10/22/2026
Terms of Clearance: Previous terms continue: Approved consistent with the understanding that GenICs under this generic will be limited to acute public health emergencies resulting from outbreaks or events with undetermined agent, source, mode of transmission, or risk factors. Data collection for investigations conducted under this generic will not exceed 90 days. Investigations conducted for the primary purpose of program evaluation, surveillance, needs assessment, or research (e.g., to contribute to generalizable knowledge) are excluded from this generic pathway.

	Inventory as of this Action	Requested	Previously Approved
Expiration Date	12/31/2028	12/31/2028	12/31/2028
Responses	12,000	0	12,000
Time Burden (Hours)	6,000	0	6,000
Cost Burden (Dollars)	0	0	0

Abstract: The EEI Generic ICR is specifically designed to support CDC mission-critical functions by allowing CDC to deploy to the field to conduct Emergency Epidemic Investigations (EEIs) at the request of, and under the public health authority of, external partners seeking support for a rapid response to urgent public health problems. Recent investigation that have benefited from this EEI Generic ICR included the early response to the COVID 19 Pandemic, Monkeypox outbreak, and E-cigarette or Vaping Use-Associated Lung Injury (EVALI), among other high profile acute public health events. In these situations, insufficient information is available to allow for development of data collection instruments before the response team travels to the field. Data collection instruments and methods must be rapidly created and implemented, usually while investigators are in the field, to direct appropriate public health action. Often specific questions will change or new questions will evolve during the course of the investigation as new information is revealed. While most EEIs involve 2 to 3 weeks of data collection, data collections might take longer. Data collection for investigations conducted under this generic will not exceed 90 days. If data collection is required for a longer period of time, a new request will be submitted to OMB explaining the circumstances for the extended data collection and providing the forms that will be used for that collection (by this point, the content and scope of the inquiry should be clearer). This Non-Substantive Change Request is submitted to the EEI GenIC approved for [NCEZID] Increased rates of Cladophialophora bantiana cases across the United States, 2020-present. Changes are requested in response to feedback received from state and local health department colleagues to help in data collection efforts. CDC does not consider this to be a substantive change to the survey tool and does not anticipate this change will add to the estimated time it will take for importers to complete the form.

Authorizing Statute(s): US Code: 42 USC 301 Name of Law: PHSA

Citations for New Statutory Requirements: None

Associated Rulemaking Information
RIN:	Stage of Rulemaking:	Federal Register Citation:	Date:
	Not associated with rulemaking

Federal Register Notices & Comments
60-day Notice:	Federal Register Citation:	Citation Date:
	90 FR 25279	06/16/2025
30-day Notice:	Federal Register Citation:	Citation Date:
	90 FR 46893	09/30/2025
Did the Agency receive public comments on this ICR? No

Number of Information Collection (IC) in this ICR: 1

IC Title	Form No.	Form Name
[NCEZID] Increased rates of Cladophialophora bantiana cases across the United States, 2020-present	0920-1011, 0920-1011	,

ICR Summary of Burden

	Total Approved	Previously Approved
Annual Number of Responses	12,000	12,000
Annual Time Burden (Hours)	6,000	6,000
Annual Cost Burden (Dollars)	0	0

Burden increases because of Program Change due to Agency Discretion: No

Burden Increase Due to:

Burden decreases because of Program Change due to Agency Discretion: No

Burden Reduction Due to:

Short Statement:

Annual Cost to Federal Government: $2,130,576

Does this IC contain surveys, censuses, or employ statistical methods? Yes Part B of Supporting Statement

Does this ICR request any personally identifiable information (see OMB Circular No. A-130 for an explanation of this term)? Please consult with your agency's privacy program when making this determination. No

Does this ICR include a form that requires a Privacy Act Statement (see 5 U.S.C. §552a(e)(3))? Please consult with your agency's privacy program when making this determination. Yes

Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]? No

Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]? No

Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)? No

Is this ICR related to the Pandemic Response? Yes

Agency Contact: Jeffrey Zirger 404 639-7118 wtj5@cdc.gov

View Generic ICR - OIRA Conclusion